NeuraLight Secures $25 Million Series A to Develop Precision Medicine for Neurological Diseases using Computer Vision and Smartphones

Press/Media

Period	24 May 2022

Media coverage

Title	NeuraLight Secures $25 Million Series A to Develop Precision Medicine for Neurological Diseases using Computer Vision and Smartphones
Media name/outlet	WebWire
Country/Territory	United States
Date	24/05/22
URL	https://www.webwire.com/ViewPressRel.asp?aId=289461
Persons	Fred Lublin